# Evaluation of the Role of Acetyl Cysteine in Ventilator Associated Pneumonia by Carbapenem Resistance Klebsiella

> **NCT07097727** · PHASE1 · COMPLETED · sponsor: **Tanta University** · enrollment: 70 (actual)

## Conditions studied

- Ventilator Associated Pneumonia ( VAP)
- Mechanical Ventilation

## Interventions

- **DRUG:** acetyl cysteine 600 mg
- **DRUG:** antibiotics and saline.

## Key facts

- **NCT ID:** NCT07097727
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-10-30
- **Primary completion:** 2024-09-30
- **Final completion:** 2024-10-30
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2025-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07097727

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07097727, "Evaluation of the Role of Acetyl Cysteine in Ventilator Associated Pneumonia by Carbapenem Resistance Klebsiella". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07097727. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*